By Staff
Friday, June 9, 2023 3:34 PM
Specsavers announces that it has become a Participating Gold Sponsor of the Canadian Council of the Blind (CCB), whose mission is to improve the quality of life of people who are blind, deaf-blind or living with low vision through efforts that support individuals and communities.
By Staff
Friday, June 9, 2023 3:26 PM
Artificial intelligence (AI) has been helping businesses deliver the best service for their customers, meanwhile, helping said customers build closer relationships with their favorite brands.
By Staff
Friday, June 9, 2023 2:56 PM
Americans are seeing their taxes climb according to a new report from
USAFacts. The data agency reports that the level of taxation rose in several states across the U.S. with the highest levels of taxation in Washington and Hawaii.
General sales tax made up 32 percent of local and state government tax revenue in 2020. These taxes are applied to goods and services and are collected to help cover the cost of local and state expenditures such as infrastructure.
States with the lowest tax burden include Alaska, Vermont and Maryland. In 2020, Alaskans paid on average $340 per capita, or a rate of 0.5 percent of personal income. Vermont collected $720 or 1.2 percent of personal income.
By Staff
Friday, June 9, 2023 2:22 PM
HEIDELBERG, Germany and CAMBRIDGE, Mass.—Novaliq GmbH, a biopharmaceutical company focusing on ocular therapeutics, announced that the U.S. Food and Drug Administration (FDA) has approved Vevye (cyclosporine ophthalmic solution) 0.1% for the treatment of the signs and symptoms of dry eye disease. Vevye (development name CyclASol) is the first and only cyclosporine solution indicated for the treatment of signs and symptoms of dry eye disease with efficacy demonstrated after four weeks of treatment, according to the company.
Read More
By Staff
Friday, June 9, 2023 2:08 PM
Wilzen Lingad, OD, moved from her home country of Switzerland to New York City on her own at age 19. She worked her way through SUNY and gained experience as an associate OD for a number of years. But the slow, early days of the pandemic got her thinking of being her own boss, and in September 2021, her year-long passion project turned into Bridges Eye Care in Queens, Long Island, New York. Sitting at the foot of the Manhattan Bridge, Bridges Eye Care started as a “blank space” with no electricity meter or water line. Dr. Lingad saw the opportunity to let her creativity run wild, even creating both hand-drawn sketches and an “entire PDF of the practice design.”
Read More
By Staff
Friday, June 9, 2023 10:51 AM
In the Eastern U.S., wildfire smoke is the biggest topic of conversation right now. But in Eastern Canada,
smoke and fire are causing destruction and devastation. Head over to
The Cut for a look at how you can help those impacted by wildfires in Canada.
By Staff
Friday, June 9, 2023 8:20 AM
Did you follow the optical news this week? Take VM’s News Quiz to see how much you know. This week's quiz takes a look at Apple’s Vision Pro Headset, air quality alerts and an Eye Health Summit.
By Staff
Friday, June 9, 2023 8:10 AM
This mug is the perfect way to sip on your morning coffee. You can buy it in a variety of colors on Etsy
here. #WeShareIt
By Staff
Friday, June 9, 2023 8:02 AM
The U.S. Food and Drug Administration on Tuesday approved Cue Health's at-home COVID-19 test, the first coronavirus test to get marketing authorization using a traditional premarket review, the agency said.
By Staff
Friday, June 9, 2023 8:02 AM
White House COVID coordinator Ashish Jha will step down next week as the Biden administration formally ends the role, the latest marker that officials believe the virus threat has largely passed.
By Staff
Friday, June 9, 2023 12:27 AM
Novaliq announces FDA approval of Vevye 0.1%; Prevent Blindness provides education and resources on the effects of vision loss on mental health; Optical retailer Fielmann Group enters U.S. market; Registration opens for Vision Expo West 2023; and The Vision Council releases Provider inSights Survey all topped this week’s
VMAIL news feed. Click on the headlines below to catch up on anything you might have missed.
By Staff
Friday, June 9, 2023 12:24 AM
HEIDELBERG, Germany and CAMBRIDGE, Mass.—
Novaliq GmbH, a biopharmaceutical company focusing on ocular therapeutics, announced that the U.S. Food and Drug Administration (FDA) has approved Vevye (cyclosporine ophthalmic solution) 0.1% for the treatment of the signs and symptoms of dry eye disease. Vevye (development name CyclASol) is the first and only cyclosporine solution indicated for the treatment of signs and symptoms of dry eye disease with efficacy demonstrated after four weeks of treatment, according to the company.